Candel Therapeutics(CADL) - 2025 Q4 - Annual Results
Candel TherapeuticsCandel Therapeutics(US:CADL)2026-02-19 21:03

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2026 CANDEL THERAPEUTICS, INC. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) 117 Kendrick St Suite 450 Needham, Massachusetts 02494 (Address of Principal Executive Offices) (Zip Code) Delaware 001-40629 52-2214851 (Commission ...